These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31392665)

  • 1. Developing Open-Source Models for the US Health System: Practical Experiences and Challenges to Date with the Open-Source Value Project.
    Jansen JP; Incerti D; Linthicum MT
    Pharmacoeconomics; 2019 Nov; 37(11):1313-1320. PubMed ID: 31392665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Flexible Open-Source Decision Model for Value Assessment of Biologic Treatment for Rheumatoid Arthritis.
    Incerti D; Curtis JR; Shafrin J; Lakdawalla DN; Jansen JP
    Pharmacoeconomics; 2019 Jun; 37(6):829-843. PubMed ID: 30737711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toward Relevant and Credible Cost-Effectiveness Analyses for Value Assessment in the Decentralized U.S. Health Care System.
    Jansen JP; Incerti D; Curtis JR
    J Manag Care Spec Pharm; 2019 May; 25(5):518-521. PubMed ID: 31039069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Achieving Appropriate Model Transparency: Challenges and Potential Solutions for Making Value-Based Decisions in the United States.
    Carlson JJ; Walton SM; Basu A; Chapman RH; Campbell JD; McQueen RB; Pearson SD; Touchette DR; Veenstra D; Whittington MD; Ollendorf DA
    Pharmacoeconomics; 2019 Nov; 37(11):1321-1327. PubMed ID: 31485925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating Expected Costs and Benefits of Granting Access to New Treatments on the Basis of Progression-Free Survival in Non-Small-Cell Lung Cancer.
    Lakdawalla DN; Chou JW; Linthicum MT; MacEwan JP; Zhang J; Goldman DP
    JAMA Oncol; 2015 May; 1(2):196-202. PubMed ID: 26181023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The project data sphere initiative: accelerating cancer research by sharing data.
    Green AK; Reeder-Hayes KE; Corty RW; Basch E; Milowsky MI; Dusetzina SB; Bennett AV; Wood WA
    Oncologist; 2015 May; 20(5):464-e20. PubMed ID: 25876994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk management frameworks for human health and environmental risks.
    Jardine C; Hrudey S; Shortreed J; Craig L; Krewski D; Furgal C; McColl S
    J Toxicol Environ Health B Crit Rev; 2003; 6(6):569-720. PubMed ID: 14698953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-Effectiveness and Value of Information of Erlotinib, Afatinib, and Cisplatin-Pemetrexed for First-Line Treatment of Advanced EGFR Mutation-Positive Non-Small-Cell Lung Cancer in the United States.
    Ting J; Tien Ho P; Xiang P; Sugay A; Abdel-Sattar M; Wilson L
    Value Health; 2015 Sep; 18(6):774-82. PubMed ID: 26409604
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Generalisability in economic evaluation studies in healthcare: a review and case studies.
    Sculpher MJ; Pang FS; Manca A; Drummond MF; Golder S; Urdahl H; Davies LM; Eastwood A
    Health Technol Assess; 2004 Dec; 8(49):iii-iv, 1-192. PubMed ID: 15544708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transparency in Health Economic Modeling: Options, Issues and Potential Solutions.
    Wu EQ; Zhou ZY; Xie J; Metallo C; Thokala P
    Pharmacoeconomics; 2019 Nov; 37(11):1349-1354. PubMed ID: 31591672
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The patient experience of patient-centered communication with nurses in the hospital setting: a qualitative systematic review protocol.
    Newell S; Jordan Z
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):76-87. PubMed ID: 26447009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effectiveness of internet-based e-learning on clinician behavior and patient outcomes: a systematic review protocol.
    Sinclair P; Kable A; Levett-Jones T
    JBI Database System Rev Implement Rep; 2015 Jan; 13(1):52-64. PubMed ID: 26447007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving the quality of workers' compensation health care delivery: the Washington State Occupational Health Services Project.
    Wickizer TM; Franklin G; Plaeger-Brockway R; Mootz RD
    Milbank Q; 2001; 79(1):5-33. PubMed ID: 11286095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of health economics modelling in rheumatoid arthritis.
    Emery P
    Pharmacoeconomics; 2004; 22(2 Suppl 1):55-69. PubMed ID: 15157004
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Can Economic Model Transparency Improve Provider Interpretation of Cost-Effectiveness Analysis? A Response.
    Cohen JT; Wong JB
    Med Care; 2017 Nov; 55(11):912-914. PubMed ID: 29028754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TECH-VER: A Verification Checklist to Reduce Errors in Models and Improve Their Credibility.
    Büyükkaramikli NC; Rutten-van Mölken MPMH; Severens JL; Al M
    Pharmacoeconomics; 2019 Nov; 37(11):1391-1408. PubMed ID: 31705406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ISPOR Good Practices for Quality Improvement of Cost-Effectiveness Research Task Force Report.
    McGhan WF; Al M; Doshi JA; Kamae I; Marx SE; Rindress D
    Value Health; 2009; 12(8):1086-99. PubMed ID: 19744291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Now Is the Time for Transparency in Value-Based Healthcare Decision Modeling.
    Hay JW
    Value Health; 2019 May; 22(5):564-569. PubMed ID: 31104735
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.